FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944778862> ?p ?o ?g. }

• W2944778862 abstract "Interferon alpha (IFNa) monotherapy is recommended as the standard therapy in polycythemia vera (PV) but not in chronic myeloid leukemia (CML). Here, we investigated the mechanisms of IFNa efficacy in JAK2V617F- vs. BCR-ABL-positive cells. Gene expression microarrays and RT-qPCR of PV vs. CML patient PBMCs and CD34+ cells and of the murine cell line 32D expressing JAK2V617F or BCR-ABL were used to analyze and compare interferon-stimulated gene (ISG) expression. Furthermore, using CRISPR/Cas9n technology, targeted disruption of STAT1 or STAT2, respectively, was performed in 32D-BCR-ABL and 32D-JAK2V617F cells to evaluate the role of these transcription factors for IFNa efficacy. The knockout cell lines were reconstituted with STAT1, STAT2, STAT1Y701F, or STAT2Y689F to analyze the importance of wild-type and phosphomutant STATs for the IFNa response. ChIP-seq and ChIP were performed to correlate histone marks with ISG expression. Microarray analysis and RT-qPCR revealed significant upregulation of ISGs in 32D-JAK2V617F but downregulation in 32D-BCR-ABL cells, and these effects were reversed by tyrosine kinase inhibitor (TKI) treatment. Similar expression patterns were confirmed in human cell lines, primary PV and CML patient PBMCs and CD34+ cells, demonstrating that these effects are operational in patients. IFNa treatment increased Stat1, Stat2, and Irf9 mRNA as well as pY-STAT1 in all cell lines; however, viability was specifically decreased in 32D-JAK2V617F. STAT1 or STAT2 knockout and reconstitution with wild-type or phospho-deficient STAT mutants demonstrated the necessity of STAT2 for IFNa-induced STAT1 phosphorylation in BCR-ABL- but not in JAK2V617F-expressing cells. STAT1 was essential for IFNa activity in both BCR-ABL- and JAK2V617F-positive cells. Furthermore, ChIP experiments demonstrate higher repressive and lower active chromatin marks at the promoters of ISGs in BCR-ABL-expressing cells. JAK2V617F but not BCR-ABL sensitizes MPN cells to interferon, and this effect was dependent on STAT1. Moreover, STAT2 is a survival factor in BCR-ABL- and JAK2V617F-positive cells but an IFNa-sensitizing factor solely in 32D-JAK2V617F cells by upregulation of STAT1 expression." @default.
• W2944778862 created "2019-05-16" @default.
• W2944778862 creator A5005641797 @default.
• W2944778862 creator A5006699052 @default.
• W2944778862 creator A5012373061 @default.
• W2944778862 creator A5012774178 @default.
• W2944778862 creator A5017588184 @default.
• W2944778862 creator A5018099107 @default.
• W2944778862 creator A5041947719 @default.
• W2944778862 creator A5044355331 @default.
• W2944778862 creator A5057250270 @default.
• W2944778862 creator A5067067865 @default.
• W2944778862 creator A5069865401 @default.
• W2944778862 creator A5077905100 @default.
• W2944778862 date "2019-04-02" @default.
• W2944778862 modified "2023-10-12" @default.
• W2944778862 title "Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha" @default.
• W2944778862 cites W1419799953 @default.
• W2944778862 cites W1489608758 @default.
• W2944778862 cites W1489693342 @default.
• W2944778862 cites W1983989619 @default.
• W2944778862 cites W1987485969 @default.
• W2944778862 cites W2000177767 @default.
• W2944778862 cites W2006917576 @default.
• W2944778862 cites W2012153991 @default.
• W2944778862 cites W2015113479 @default.
• W2944778862 cites W2019665042 @default.
• W2944778862 cites W2028959752 @default.
• W2944778862 cites W2030170890 @default.
• W2944778862 cites W2034491071 @default.
• W2944778862 cites W2038771520 @default.
• W2944778862 cites W2045423970 @default.
• W2944778862 cites W2049145190 @default.
• W2944778862 cites W2057360098 @default.
• W2944778862 cites W2059284045 @default.
• W2944778862 cites W2061303590 @default.
• W2944778862 cites W2066079888 @default.
• W2944778862 cites W2073033866 @default.
• W2944778862 cites W2078844752 @default.
• W2944778862 cites W2080339897 @default.
• W2944778862 cites W2091005492 @default.
• W2944778862 cites W2093418105 @default.
• W2944778862 cites W2094200744 @default.
• W2944778862 cites W2097922857 @default.
• W2944778862 cites W2104113680 @default.
• W2944778862 cites W2105899429 @default.
• W2944778862 cites W2106227592 @default.
• W2944778862 cites W2112817157 @default.
• W2944778862 cites W2112895187 @default.
• W2944778862 cites W2115351357 @default.
• W2944778862 cites W2117453887 @default.
• W2944778862 cites W2121743767 @default.
• W2944778862 cites W2122224021 @default.
• W2944778862 cites W2122395736 @default.
• W2944778862 cites W2138282709 @default.
• W2944778862 cites W2147370660 @default.
• W2944778862 cites W2147666686 @default.
• W2944778862 cites W2151712105 @default.
• W2944778862 cites W2160968988 @default.
• W2944778862 cites W2167380395 @default.
• W2944778862 cites W2167778120 @default.
• W2944778862 cites W2187652773 @default.
• W2944778862 cites W2191128990 @default.
• W2944778862 cites W2301643381 @default.
• W2944778862 cites W2317901346 @default.
• W2944778862 cites W2337277825 @default.
• W2944778862 cites W2351294632 @default.
• W2944778862 cites W2542515380 @default.
• W2944778862 cites W2564723484 @default.
• W2944778862 cites W2775016799 @default.
• W2944778862 cites W2901966462 @default.
• W2944778862 cites W4242351610 @default.
• W2944778862 doi "https://doi.org/10.1186/s13045-019-0722-9" @default.
• W2944778862 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6444528" @default.
• W2944778862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30940163" @default.
• W2944778862 hasPublicationYear "2019" @default.
• W2944778862 type Work @default.
• W2944778862 sameAs 2944778862 @default.
• W2944778862 citedByCount "18" @default.
• W2944778862 countsByYear W29447788622019 @default.
• W2944778862 countsByYear W29447788622020 @default.
• W2944778862 countsByYear W29447788622021 @default.
• W2944778862 countsByYear W29447788622022 @default.
• W2944778862 countsByYear W29447788622023 @default.
• W2944778862 crossrefType "journal-article" @default.
• W2944778862 hasAuthorship W2944778862A5005641797 @default.
• W2944778862 hasAuthorship W2944778862A5006699052 @default.
• W2944778862 hasAuthorship W2944778862A5012373061 @default.
• W2944778862 hasAuthorship W2944778862A5012774178 @default.
• W2944778862 hasAuthorship W2944778862A5017588184 @default.
• W2944778862 hasAuthorship W2944778862A5018099107 @default.
• W2944778862 hasAuthorship W2944778862A5041947719 @default.
• W2944778862 hasAuthorship W2944778862A5044355331 @default.
• W2944778862 hasAuthorship W2944778862A5057250270 @default.
• W2944778862 hasAuthorship W2944778862A5067067865 @default.
• W2944778862 hasAuthorship W2944778862A5069865401 @default.
• W2944778862 hasAuthorship W2944778862A5077905100 @default.
• W2944778862 hasBestOaLocation W29447788621 @default.
• W2944778862 hasConcept C104317684 @default.
• W2944778862 hasConcept C117705580 @default.

• next